For more information or confidential assistance
Call 800-306-3180

Male Breast Growth Topic of Risperdal Lawsuit

According to a recent product liability lawsuit, defendants Johnson & Johnson and Janssen Pharmaceuticals knew that Risperidone was defective and likely to cause male breast growth in patients, but still engaged in illegal marketing practices to promote the drug. The antipsychotic medication, which is sold... Read More

Man Files Risperdal Lawsuit Over Male Breast Growth

A Louisiana man has filed a Risperdal lawsuit over male breast growth (gynecomastia). The plaintiff filed the complaint against Janssen Pharmaceuticals, Inc., Johnson & Johnson, and Janssen Research and Development LLC, in the United States District Court for the Western District of Louisiana (Shreveport Division). Hundreds... Read More

New Risperdal and Gynecomastia Study Fuels Lawsuits

Risperdal Lawsuit
Middle-aged men who take Risperdal are 69 percent more likely to develop larger breasts (gynecomastia) than men who are not taking antipsychotic drugs, according to a new Risperdal and gynecomastia study published in the Journal of Clinical Psychopharmacology on August 6, 2014. "There has been... Read More